Serum Metabolomic and Lipidomic Profiling Reveals Novel Biomarkers of Efficacy for Benfotiamine in Alzheimer’s Disease
Serum metabolomics and lipidomics are powerful approaches for discovering unique biomarkers in various diseases and associated therapeutics and for revealing metabolic mechanisms of both. Treatment with Benfotiamine (BFT), a thiamine prodrug, for one year produced encouraging results for patients wi...
Main Authors: | Ruchika Bhawal, Qin Fu, Elizabeth T. Anderson, Gary E. Gibson, Sheng Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/24/13188 |
Similar Items
-
Safety, Tolerability and Pharmacokinetics of Single and Multiple Ascending Doses of Benfotiamine in Healthy Subjects
by: Sheng L, et al.
Published: (2021-03-01) -
Thiamine and benfotiamine: Focus on their therapeutic potential
by: Iva Bozic, et al.
Published: (2023-11-01) -
Chemoreactomic analysis of thiamine disulfide, thiamine hydrochloride, and benfotiamine molecules
by: O. A. Gromova, et al.
Published: (2017-07-01) -
Pharmacological thiamine levels as a therapeutic approach in Alzheimer's disease
by: Gary E. Gibson, et al.
Published: (2022-10-01) -
Benfotiamine, thiamine monophosphate chloride and thiamine pyrophosphate chloride, as sources of vitamin B1 added for nutritional purposes to food supplements ‐ Scientific Opinion of the Panel on Food Additives and Nutrient Sources added to Food (ANS)
by: European Food Safety Authority (EFSA)
Published: (2008-11-01)